|
Recent Developments |
|
23-SEP-16
Lincoln Pharma has launched Ondansetron Oral Spray (Domi Up) in the dosage form of 0.2 ml equivalent to 2 mg and 0.4 ml equivalent to 4 mg.
02-SEP-16
Lincoln Pharmaceuticals, engaged in manufacturing pharma products like Tablets, Capsules, Injectable, Syrups, Ointments, etc. at its state of art, fully automated, ultramodern, WHO-GMP standards and 150-9001 certified manufacturing activities near Ahmedabad.
18-JAN-16
Ahmedabad-based... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Brief Financials (in Rs. Mn.) | |
| Period ending (months) | 30-Sep-2015(6) | 31-Mar-2015(12) | 31-Mar-2014 (12) | | Net sales | 1332.96 | 2232.60 | 2047.81 | | Other Income | 0.00 | 0.00 | 0.00 | | Total Income | 1332.96 | 2232.60 | 2047.81 | | Cost of goods sold | 1204.57 | 2001.51 | 1896.91 | | OPBDIT | 128.39 | 231.09 | 150.90 | | PAT | 115.12 | 147.73 | 114.28 | | Gross Block | - | - | - | | Equity capital | 163.11 | 163.11 | 163.11 | | EPS (Rs.) | - | - | 7.00 | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | - | 3.24 - 7.67 | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 9.6 | 10.4 | 7.4 | | Net margin (% of OI) | 8.6 | 6.6 | 5.6 |
|
|
Detailed Financials
|
|
|
|
|
